Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · IEX Real-Time Price · USD
13.01
0.00 (0.00%)
At close: Apr 24, 2024, 4:00 PM
12.77
-0.24 (-1.84%)
After-hours: Apr 24, 2024, 7:56 PM EDT
Teva Pharmaceutical Market Cap
Teva Pharmaceutical has a market cap or net worth of $14.58 billion as of April 24, 2024. Its market cap has increased by 54.45% in one year.
Market Cap
14.58B
Enterprise Value
31.51B
1-Year Change
54.45%
Ranking
Category
Stock Price
$13.01
Market Cap Chart
Since December 1, 1998, Teva Pharmaceutical's market cap has increased from $6.10B to $14.58B, an increase of 139.01%. That is a compound annual growth rate of 3.49%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 14.59B | 1.01% |
Apr 22, 2024 | 14.44B | 0.16% |
Apr 19, 2024 | 14.42B | 0.63% |
Apr 18, 2024 | 14.33B | -3.03% |
Apr 17, 2024 | 14.78B | 0.69% |
Apr 16, 2024 | 14.68B | -1.06% |
Apr 15, 2024 | 14.83B | -0.53% |
Apr 12, 2024 | 14.91B | -4.11% |
Apr 11, 2024 | 15.55B | 0.14% |
Apr 10, 2024 | 15.53B | -0.86% |
Apr 9, 2024 | 15.66B | -1.62% |
Apr 8, 2024 | 15.92B | -0.35% |
Apr 5, 2024 | 15.98B | 2.30% |
Apr 4, 2024 | 15.62B | -1.35% |
Apr 3, 2024 | 15.83B | 1.88% |
Apr 2, 2024 | 15.54B | -0.36% |
Apr 1, 2024 | 15.59B | -1.42% |
Mar 28, 2024 | 15.82B | -2.22% |
Mar 27, 2024 | 16.18B | 2.05% |
Mar 26, 2024 | 15.85B | 0.57% |
Mar 25, 2024 | 15.76B | 1.22% |
Mar 22, 2024 | 15.57B | 1.02% |
Mar 21, 2024 | 15.42B | 2.00% |
Mar 20, 2024 | 15.11B | 0.97% |
Mar 19, 2024 | 14.97B | 0.23% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Laboratory Corporation of America Holdings | 17.49B |
BioMarin Pharmaceutical | 17.47B |
Walgreens Boots Alliance | 15.57B |
Quest Diagnostics | 15.13B |
BeiGene | 14.93B |
Neurocrine Biosciences | 13.94B |
Skye Bioscience | 13.63B |
Viatris | 13.49B |